111, Inc. ( (YI) ) has released its Q2 earnings. Here is a breakdown of the information 111, Inc. presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
111, Inc. is a tech-enabled healthcare platform company based in China, focusing on enhancing the healthcare value chain through digital solutions, including online and offline pharmacy services and healthcare consultations. In its second quarter of 2025, 111, Inc. reported maintaining operational profitability and positive cash flow, despite a challenging economic environment. The company saw a 9.3% reduction in operating expenses year-over-year and a 53.6% increase in sales revenue from marketing promotional products. However, net revenues decreased by 6.4% compared to the same period last year, and the company reported a net loss of RMB7.3 million. The company continues to expand its supply chain capabilities and digital marketing reach, with a significant increase in customer count and sales volume in its general agency business model. Looking forward, 111, Inc. plans to continue leveraging technology to optimize its supply chain and enhance customer engagement, aiming to solidify its leadership in the tech-enabled healthcare sector.